For progression of atrophic gastritis and/or intestinal metaplasia, the strongest predictors were detection of Hp in gastric biopsies at baseline or follow-up, positively associated with progression, and treatment to eliminate Hp before follow-up, inversely associated with progression. The gene discussed is HP; the disease is chronic atrophic gastritis.